Uracil mustard, a new alkylating agent for oral administration in the management of patients with leukemia and lymphoma.

B. J. KENNEDY, A. THEOLOGIDES

Research output: Contribution to journalArticle

7 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)790-793
Number of pages4
JournalThe New England journal of medicine
Volume264
DOIs
StatePublished - Jan 1 1961

Fingerprint

Uracil Mustard
Uracil
Alkylating Agents
Antineoplastic Agents
Oral Administration
Lymphoma
Leukemia

Cite this

Uracil mustard, a new alkylating agent for oral administration in the management of patients with leukemia and lymphoma. / KENNEDY, B. J.; THEOLOGIDES, A.

In: The New England journal of medicine, Vol. 264, 01.01.1961, p. 790-793.

Research output: Contribution to journalArticle

@article{e8ba9d05d3a74b7cb1fcca5f9c56205a,
title = "Uracil mustard, a new alkylating agent for oral administration in the management of patients with leukemia and lymphoma.",
author = "KENNEDY, {B. J.} and A. THEOLOGIDES",
year = "1961",
month = "1",
day = "1",
doi = "10.1056/NEJM196104202641603",
language = "English (US)",
volume = "264",
pages = "790--793",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",

}

TY - JOUR

T1 - Uracil mustard, a new alkylating agent for oral administration in the management of patients with leukemia and lymphoma.

AU - KENNEDY, B. J.

AU - THEOLOGIDES, A.

PY - 1961/1/1

Y1 - 1961/1/1

UR - http://www.scopus.com/inward/record.url?scp=0345331356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345331356&partnerID=8YFLogxK

U2 - 10.1056/NEJM196104202641603

DO - 10.1056/NEJM196104202641603

M3 - Article

C2 - 13752496

AN - SCOPUS:0345331356

VL - 264

SP - 790

EP - 793

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

ER -